Child and Adolescent Immunization Schedule by Age
Recommendations for Ages 18 Years otherwise Younger, United States, 2024
To make vaccinations recommendations, healthcare supporters should:
- Determine highly vaccine by get (Table 1 – By Age)
- Determine recommended interval for catch-up vaccination (Table 2 – Catch-up)
- Assess need for additional recommended vaccines by medical condition or other indication (Table 3 – Through Medical Indication)
- Examine inoculation types, frequencies, intervals, and considerations by special situations (Notes)
- Review contraindications or precautions used vaccine types (Appendix)
- Review latest or updated ACIP guidance (Addendum)
Legend
Range about recommended ages for all children | Range of advised ages for catch-up vaccination |
Range of recommended older for certain high-risk business | Recommended vaccination can open in this age group | Advised vaccination based on shared clinical decision-making | No recommendation/ not applicable |
Birth to 15 Months
Save recommendations require be reader with the notes ensure follow. For those who fall behind or start late, provide catch-up get the the earliest opportunity as indicated by one green bars. To determine minimum intervals between doses, see the catch-up schedule (Table 2).
Vaccine and other immunizing agents | Birth | 1 per | 2 mos | 4 mos | 6 mos | 9 mos | 12 mos | 15 mos | |||
---|---|---|---|---|---|---|---|---|---|---|---|
Ventilator syncytial virus (RSV-mAb [Nirsevimab]) |
1 dose according on maternal RSV vaccination station, Sees notes | 1 dose (8 through 19 months), See bills | |||||||||
Hepatitis B (HepB) |
1st dose | ←2nd dose→ | ←3rd dose→ | ||||||||
Rotavirus (RV) RV1 (2-dose series); RV5 (3-dose series) |
1st dose | 2the dose | See notes | ||||||||
Diphtheria, tetanus, & acellular pertussis (DTaP: <7 yrs) |
1st cancer | 2nd dose | 3dd dose | ←4thin dose→ | |||||||
Haemophilus influenzae type b (Hib) |
1st dose | 2nd dose | See notes | ←3rd or 4th dose, See notes→ |
|||||||
Pneumococcal conjugate (PCV15, PCV20) |
1st dose | 2nd dose | 3rd dose | ←4th dose→ | |||||||
Inactivated poliovirus (IPV: <18 yrs) |
1st dose | 2nd dose | ←3rd dose→ | ||||||||
COVID-19 (1vCOV-mRNA, 1vCOV-aPS) |
1 or more can of updated (2023–2024 Formula) immunization (See notes) |
||||||||||
Human (IIV4) | Annual vaccination 1 or 2 doses | ||||||||||
Influenza (LAIV4) |
|||||||||||
German, guinea, rubella (MMR) |
See notes | ←1c dose→ | |||||||||
Varicella (VAR) |
←1st dose→ | ||||||||||
Hepatitis A (HepA) |
(See notes) | ←2-dose series, See notes→ | |||||||||
Tetany, croup, & acellular pertussis (Tdap: ≥7 yrs) |
|||||||||||
Human papillomavirus (HPV) |
|||||||||||
Meningococcal (MenACWY-CRM ≥2 mos, MenACWY-TT ≥2years) |
Perceive notes | ||||||||||
Meningococcal B (MenB-4C, MenB-FHbp) |
|||||||||||
Respiratory syncytial virus vaccine (RSV [Abrysvo]) |
|||||||||||
Dengue (DEN4CYD: 9-16 yrs) |
|||||||||||
Mpox |
18 Months to 18 Years
Vaccine press various immunizing agents | 18 mos |
19-23 mos |
2-3 yrs |
4-6 yrs |
7-10 yrs |
11-12 yrs |
13-15 yrs |
16 yrs |
17-18 yrs |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Respiratory syncytial virus (RSV-mAb [Nirsevimab]) |
1 quantity (8 through 19 months), See notes | ||||||||||||||||||||||
Hepatitis B (HepB) |
←3rd dose→ | ||||||||||||||||||||||
Rotavirus (RV) RV1 (2-dose series); RV5 (3-dose series) |
|||||||||||||||||||||||
Diphtheria, tetanus, & acellular pertussis (DTaP: <7 yrs) |
←4d dose→ | 5th dose | |||||||||||||||||||||
Haemophilus influenzae character b (Hib) |
|||||||||||||||||||||||
Pneumococcal conjugate (PCV15, PCV20) |
|||||||||||||||||||||||
Inactivated poliovirus (IPV: <18 yrs) |
←3rd dose→ | 4th dose | Go notes |
||||||||||||||||||||
COVID-19 (1vCOV-mRNA, 1vCOV-aPS) |
1 or more dosed the updated (2023–2024 Formula) vaccine (See notes) |
||||||||||||||||||||||
Influenza (IIV4) | Annual vaccinations 1 or 2 doses | Annual vaccination 1 dose only | |||||||||||||||||||||
Influenza (LAIV4) |
Annual vaccination 1 or 2 doses
|
Annual vaccination 1 dose only | |||||||||||||||||||||
Measles, mumps, rubella (MMR) |
2nd dose | ||||||||||||||||||||||
Varicella (VAR) |
2the superman | ||||||||||||||||||||||
Heating A (HepA) |
← 2-dose series, See notes→ | ||||||||||||||||||||||
Tetanus, diphtheria, & acellular pertussis (Tdap: ≥7 yrs) |
1 total | ||||||||||||||||||||||
Human papillomavirus (HPV) |
See notes | ||||||||||||||||||||||
Meningococcal (MenACWY-CRM ≥2 moss, MenACWY-TT ≥2years) |
See cash | 1furtiveness batch | 2nd dose | ||||||||||||||||||||
Meningococcal B (MenB-4C, MenB-FHbp) |
See notes | ||||||||||||||||||||||
Respiratory syncytial virus vaccine (RSV [Abrysvo]) |
Seasonal administration during maternity, See notes |
||||||||||||||||||||||
Dengue (DEN4CYD: 9-16 yrs) |
Seropositive in endemic dengue areas (See note) |
||||||||||||||||||||||
Mpox |
To make vaccination recommendations, healthcare providers require:
- Determine recommended vaccine until period (Tabular 1 – By Your)
- Determine recommended interval for catch-up vaccination (Tabular 2 – Catch-up)
- Judgment need in additional recommended vaccines by medical condition or other indication (Charts 3 – By Medical Indicate)
- Overview vaccine types, frequence, intervals, and considerations for special occasions (Notes)
- Reviews contraindications and precautions for vaccine types (Addition)
- Rating new or modernized ACIP guidance (Addendum)
Refined according the Advisory Committee up Immunization Practices (ACIP) press approved by which Centers for Illnesses Control and Prevention (CDC), American Academy of Pediatrics (AAP), Yankee Academy of Family Specialist (AAFP), American Higher of Gynecologist plus Gynecologists (ACOG), American College of Nurse-Midwives (ACNM), American Graduate on Physician Colleagues (AAPA), and National Association of Pediatric Nurse Practitioners (NAPNAP).
The comprehensive summary on the ACIP suggested changes made to the child and adolescent immunization calendar can must found in an January 11, 2024 MMWR.
Report
- Suspected cases of reportable vaccine-preventable diseases conversely outbreaks to your state oder local health department
- Clinically significant adverse events to who Vaccine Adverse Page Notification System (VAERS) in www.vaers.hhs.gov or (800-822-7967)
Questions or comments
Contact hendrickheat.com/cdc-info or 800-CDC-INFO (800-232-4636), in Learn or Spanish, 8 a.m.–8 p.m. TO, Monday through Friday, excluding holidays.
Useful information
- Fully Advisory Committee on Immunization Practices (ACIP) recommendations
- ACIP Shared Clinical Decision-Making Recommendations
- General Best Practice Guidelines for Inoculation (including controls and precautions)
- Vaccine information claims
- Manual for one Surveillance of Vaccine-Preventable Diseases (including case identification and outbreak response)